(Victoria Forster/ Forbes) — An innovative gel treatment has shown early promise for treating the most common type of skin cancer. The new results from a clinical trial were published in the journal Clinical Cancer Research and investigated the topical gel which contained the drug remetinostat.

Basal cell carcinoma  …